Matches in Nanopublications for { ?s ?p "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 21 of
21
with 100 items per page.
- NP745407.RArhA6Z4tjFWksZGVBpQ9l79L0iwOUbsX0NYMrefwWoXM130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745407.RArhA6Z4tjFWksZGVBpQ9l79L0iwOUbsX0NYMrefwWoXM130_provenance.
- NP916598.RAdaMwwVu04hYnoaebJ0uinfI1Hng8ZIRqBYTFnWF9N40130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916598.RAdaMwwVu04hYnoaebJ0uinfI1Hng8ZIRqBYTFnWF9N40130_provenance.
- NP919886.RAQvUnADavnCJ1aTo2Nt8z1PV39oumsGkb42QZFAYMAFw130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919886.RAQvUnADavnCJ1aTo2Nt8z1PV39oumsGkb42QZFAYMAFw130_provenance.
- NP756081.RAW6UnHd9NLO0MHu3EFIKcpsrltnLX8UIVlQSE9X2bxvA130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756081.RAW6UnHd9NLO0MHu3EFIKcpsrltnLX8UIVlQSE9X2bxvA130_provenance.
- NP376151.RAOhJGPQECENSoo2JUDWXU2FkpUZwCCTIibQKuc-g6rro130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376151.RAOhJGPQECENSoo2JUDWXU2FkpUZwCCTIibQKuc-g6rro130_provenance.
- NP611601.RA6OXRyt_3tIqOndT5kGFHrP7BfOIdwyTvyfegkKwz0e0130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611601.RA6OXRyt_3tIqOndT5kGFHrP7BfOIdwyTvyfegkKwz0e0130_provenance.
- NP692973.RAauv1dla2JDiFrhsHKOIKlZY7AnHDLMCXSWXczYDw6b0130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692973.RAauv1dla2JDiFrhsHKOIKlZY7AnHDLMCXSWXczYDw6b0130_provenance.
- NP693079.RAUDU3ts1nkhsIrgqnx9M1RLMGPDdhckDp_esvRBkYPuk130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693079.RAUDU3ts1nkhsIrgqnx9M1RLMGPDdhckDp_esvRBkYPuk130_provenance.
- assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1313605.RAeOgbaXUcg4uYhMbms69MRFR0e3EGjP2DzzHi38q-eCI130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313605.RAeOgbaXUcg4uYhMbms69MRFR0e3EGjP2DzzHi38q-eCI130_provenance.
- NP1313608.RAnBartex0fIs4W7FytFwTN3YDnxeI_ekqhHB2huYorqY130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313608.RAnBartex0fIs4W7FytFwTN3YDnxeI_ekqhHB2huYorqY130_provenance.
- NP692808.RA3u1svGG9en88wxAmokgH_zPXN75P_bIIiowizp8n-ko130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692808.RA3u1svGG9en88wxAmokgH_zPXN75P_bIIiowizp8n-ko130_provenance.
- NP692972.RA32TIV-YDVJhQsyZ-ARTpwsqqLRQ69TQkAkijHWxfiJ0130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692972.RA32TIV-YDVJhQsyZ-ARTpwsqqLRQ69TQkAkijHWxfiJ0130_provenance.
- NP692974.RA47lUheH7DzchihS2brG55DzJC9JS2PULxC-84uUly0g130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692974.RA47lUheH7DzchihS2brG55DzJC9JS2PULxC-84uUly0g130_provenance.
- NP1313607.RALuni6KK645qlTowCp5LCyLfJGkQJoQfs-eAkV9K514I130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313607.RALuni6KK645qlTowCp5LCyLfJGkQJoQfs-eAkV9K514I130_provenance.
- NP1313604.RAzBUe3Hk9OcQtDA47w6z-Q_IeSASezjz03TIxQ1f6OKE130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313604.RAzBUe3Hk9OcQtDA47w6z-Q_IeSASezjz03TIxQ1f6OKE130_provenance.
- NP1313606.RAw_4nI_vAqkNmv4dQm1GY6i2x7_7vtXgS_U96kovRV-c130_assertion description "[Relative overexpression of SHBG mRNA was observed in six out of 22 cases (27%) of ovarian cancer (three cases of endometrioid adenocarcinoma, two cases of serous cystadenocarcinoma and one case of mucinous cystadenocarcinoma) in comparison with normal ovaries and benign ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313606.RAw_4nI_vAqkNmv4dQm1GY6i2x7_7vtXgS_U96kovRV-c130_provenance.